NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

Children exposed to second-hand smoke at home are more likely to show certain changes in the epigenome, which can alter the ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant access to gene-editing therapy on the NHS.

By Gene Nichol Late last week, President Donald Trump issued an executive order gutting DEI (diversity, equity and inclusion) programs in the federal government. Employees in DEI offices were placed ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

NHS approves £1.65m gene therapy for sickle cell disease, offering a potential cure. A milestone for patients, especially in ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

The NHS has launched a new genetic blood test to improve the safety of kidney donations from people of Black African and Black Caribbean heritage ...